Client News
nova funds GmbH: Gesundheitsaktienfonds nova Steady HealthCare mit FundAward 2020 ausgezeichnet
29th January 2020
Abivax to Host Satellite Symposium at 15th Congress of the European Crohn’s and Colitis Organization (ECCO) in Vienna
28th January 2020
AFFiRiS Announces FDA Response to its pre-IND Submission for Phase 2 Trial with AFFITOPE® PD01 in Early Parkinson’s Disease Patients
27th January 2020
4basebio AG decides to buy back 2 million treasury shares
21st January 2020
Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB
21st January 2020
Abivax receives clearance from U.S. FDA to initiate clinical trials with ABX464 to treat moderate to severe ulcerative colitis
20th January 2020
nova funds GmbH: Gesundheitsaktienfonds nova Steady HealthCare setzt ausgezeichnete Wertentwicklung fort
15th January 2020
Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy
13th January 2020
There is no more content to load